Skip to main content
. 2020 Dec 8;121(3):793–801. doi: 10.1007/s00421-020-04570-8

Fig. 2.

Fig. 2

Fasted circulating plasma asprosin concentrations in oral contraceptive (OC) users and non-users (non-OC) in the early follicular (EF; first 6 days), late follicular (LF; days 9–13) and mid-luteal (ML; days 19–23) mensural cycle phases (or time point equivalent for OC users). Significantly lower than ML, within non-OC; *significantly lower than EF, within OC; #significantly higher compared to OC; p < 0.05